Please click here for publications from the current year
Please click here for publications from other years
Author(s) | Title | Year | Citation |
---|---|---|---|
Schultz-Cherry S, Webby RJ, Webster RG, Kelso A, Barr IG, McCauley JW, Daniels RS, Wang D, Shu Y, Nobusawa E, Itamura S, Tashiro M, Harada Y, Watanabe S, Odagiri T, Ye Z, Grohmann G, Harvey R, Engelhardt O, Smith D, Hamilton K, Claes F and Dauphin G | Influenza gain-of-function experiments: their role in vaccine virus recommendation and pandemic preparedness | 2014 | MBio 5(6). PubMed link DOI:10.1128/mBio.02430-14 |
Jegaskanda S, Vandenberg K, Laurie KL, Loh L, Kramski M, Winnall WR, Kedzierska K, Rockman S and Kent SJ | Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses | 2014 | J Infect Dis 210(11): 1811-1822. PubMed link DOI:10.1093/infdis/jiu334 |
Perera HK, Vijaykrishna D, Premarathna AG, Jayamaha CJ, Wickramasinghe G, Cheung CL, Yeung MF, Poon LL, Perera AK, Barr IG, Guan Y and Peiris M | Molecular Epidemiology of Influenza A(H1N1)pdm09 Virus among Humans and Swine, Sri Lanka | 2014 | Emerg Infect Dis 20(12): 2080-2084. PubMed link DOI:10.3201/eid2012.140842 |
Sullivan SG, Feng S and Cowling BJ | Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review | 2014 | Expert Rev Vaccines 13(12): 1571-1591. PubMed link DOI:10.1586/14760584.2014.966695 |
Fonville JM, Wilks SH, James SL, Fox A, Ventresca M, Aban M, Xue L, Jones TC, Le NM, Pham QT, Tran ND, Wong Y, Mosterin A, Katzelnick LC, Labonte D, Le TT, van der Net G, Skepner E, Russell CA, Kaplan TD, Rimmelzwaan GF, Masurel N, de Jong JC, Palache A, Beyer WE, Le QM, Nguyen TH, Wertheim HF, Hurt AC, Osterhaus AD, Barr IG, Fouchier RA, Horby PW and Smith DJ | Antibody landscapes after influenza virus infection or vaccination | 2014 | Science 346(6212): 996-1000. PubMed link DOI:10.1126/science.1256427 |
Russ BE, Olshanksy M, Smallwood HS, Li J, Denton AE, Prier JE, Stock AT, Croom HA, Cullen JG, Nguyen ML, Rowe S, Olson MR, Finkelstein DB, Kelso A, Thomas PG, Speed TP, Rao S and Turner SJ | Distinct epigenetic signatures delineate transcriptional programs during virus-specific CD8(+) T cell differentiation | 2014 | Immunity 41(5): 853-865. PubMed link DOI:10.1016/j.immuni.2014.11.001 |
Donis RO, Influenza Cell Culture Working Group | Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing | 2014 | Vaccine 32(48): 6583-6590. PubMed link DOI:10.1016/j.vaccine.2014.06.045 |
Horm SV, Mardy S, Rith S, Ly S, Heng S, Vong S, Kitsutani P, Ieng V, Tarantola A, Sar B, Chea N, Sokhal B, Barr I, Kelso A, Horwood PF, Timmermans A, Hurt A, Lon C, Saunders D, Ung SA, Asgari N, Roces MC, Touch S, Komadina N and Buchy P | Epidemiological and virological characteristics of influenza viruses circulating in Cambodia from 2009 to 2011 | 2014 | PLoS One 9(10): e110713. PubMed link DOI:10.1371/journal.pone.0110713 |
Hurt AC | The epidemiology and spread of drug resistant human influenza viruses | 2014 | Curr Opin Virol 8: 22-29. PubMed link DOI:10.1016/j.coviro.2014.04.009 |
Meijer A, Rebelo-de-Andrade H, Correia V, Besselaar T, Drager-Dayal R, Fry A, Gregory V, Gubareva L, Kageyama T, Lackenby A, Lo J, Odagiri T, Pereyaslov D, Siqueira MM, Takashita E, Tashiro M, Wang D, Wong S, Zhang W, Daniels RS and Hurt AC | Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013 | 2014 | Antiviral Res 110: 31-41. PubMed link DOI:10.1016/j.antiviral.2014.07.001 |
Levy A, Sullivan SG, Tempone SS, Wong KL, Regan AK, Dowse GK, Effler PV and Smith DW | Influenza vaccine effectiveness estimates for Western Australia during a period of vaccine and virus strain stability, 2010 to 2012 | 2014 | Vaccine. PubMed link DOI: 10.1016/j.vaccine.2014.08.066 |
Oh DY, Lowther S, McCaw JM, Sullivan SG, Leang SK, Haining J, Arkinstall R, Kelso A, McVernon J, Barr IG, Middleton D and Hurt AC | Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact | 2014 | J Antimicrob Chemother 69(9): 2458-2469. PubMed link DOI:10.1093/jac/dku146 |
Hsu JP, Zhao X, Chen MI, Cook AR, Lee V, Lim WY, Tan L, Barr IG, Jiang L, Tan CL, Phoon MC, Cui L, Lin R, Leo YS and Chow VT | Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore | 2014 | BMC Infect Dis 14: 414. PubMed link DOI: 10.1186/1471-2334-14-414 |
Mackenzie JS, Kelso A and Hampson A | Influenza | 2014 | Microbiol Aus(3): 133-137. Online link |
Sullivan SG, Chilver MB, Higgins G, Cheng AC and Stocks NP | Influenza vaccine effectiveness in Australia: results from the Australian Sentinel Practices Research Network | 2014 | Med J Aust 201(2): 109-111. PubMed link DOI:10.5694/mja14.00106 |
Jegaskanda S, Reading PC and Kent SJ | Influenza-Specific Antibody-Dependent Cellular Cytotoxicity: Toward a Universal Influenza Vaccine | 2014 | J Immunol 193(2): 469-475. PubMed link DOI:10.4049/jimmunol.1400432 |
Sullivan SG, Komadina N, Grant K, Jelley L, Papadakis G and Kelly H | Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match | 2014 | J Med Virol 86(6): 1017-1025. PubMed link DOI:10.1002/jmv.23847 |
Hurt AC, Vijaykrishna D, Butler J, Baas C, Maurer-Stroh S, Silva-de-la-Fuente MC, Medina-Vogel G, Olsen B, Kelso A, Barr IG and Gonzalez-Acuna D | Detection of evolutionarily distinct avian influenza A viruses in Antarctica | 2014 | MBio 5(3). PubMed link DOI:10.1128/mBio.01098-14 |
Carolan LA, Butler J, Rockman S, Guarnaccia T, Hurt AC, Reading P, Kelso A, Barr I and Laurie KL | TaqMan real time RT-PCR assays for detecting ferret innate and adaptive immune responses | 2014 | J Virol Methods 205C: 38-52. PubMed link DOI:10.1016/j.jviromet.2014.04.014 |
Sullivan SG and Barr IG | Communicating the imperfect protection from today's influenza vaccines | 2014 | Australas Epidemiol 21(1): 40-43. |
Zhou B, Lin X, Wang W, Halpin RA, Bera J, Stockwell TB, Barr IG and Wentworth DE | Universal influenza B virus genomic amplification facilitates sequencing, diagnostics, and reverse genetics | 2014 | J Clin Microbiol 52(5): 1330-1337. PubMed link DOI:10.1128/JCM.03265-13 |
Butler J, Hooper KA, Petrie S, Lee R, Maurer-Stroh S, Reh L, Guarnaccia T, Baas C, Xue L, Vitesnik S, Leang SK, McVernon J, Kelso A, Barr IG, McCaw JM, Bloom JD and Hurt AC | Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses | 2014 | PLoS Pathog 10(4): e1004065. PubMed link DOI:10.1371/journal.ppat.1004065 |
Oh DY and Hurt AC | A review of the antiviral susceptibility of human and avian influenza viruses over the last decade | 2014 | Scientifica (Cairo) 2014: 430629. PubMed link DOI:10.1155/2014/430629 |
Dewar B, Barr I and Robinson P | Hospital capacity and management preparedness for pandemic influenza in Victoria | 2014 | Aust N Z J Public Health 38(2): 184-190. PubMed link DOI:10.1111/1753-6405.12170 |
Harland KL, Day EB, Apte SH, Russ BE, Doherty PC, Turner SJ and Kelso A | Epigenetic plasticity of Cd8a locus during CD8(+) T-cell development and effector differentiation and reprogramming | 2014 | Nat Commun 5: 3547. PubMed link DOI:10.1038/ncomms4547 |
Tate MD, Job ER, Deng YM, Gunalan V, Maurer-Stroh S and Reading PC | Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection | 2014 | Viruses 6(3): 1294-1316. PubMed link DOI:10.3390/v6031294 |
Leang SK, Kwok S, Sullivan SG, Maurer-Stroh S, Kelso A, Barr IG and Hurt AC | Peramivir and laninamivir susceptibility of circulating influenza A and B viruses | 2014 | Influenza Other Respir Viruses 8(2): 135-139. PubMed link |
McVernon J, Laurie K, Faddy H, Irving D, Nolan T, Barr I, Kelso A | Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia | 2014 | Influenza Other Respir Viruses. 2014 Mar;8(2):194-200 PubMed link doi: 10.1111/irv.12225 |
Barr IG | WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013 | 2014 | Vaccine. PubMed link DOI:10.1016/j.vaccine.2014.02.014 |
Ng WC, Liong S, Tate MD, Irimura T, Denda-Nagai K, Brooks AG, Londrigan SL and Reading PC | The macrophage galactose-type lectin can function as an attachment and entry receptor for influenza virus | 2014 | J Virol 88(3): 1659-1672. PubMed link DOI:10.1128/JVI.02014-13 |
Short KR, Vissers M, de Kleijn S, Zomer AL, Kedzierska K, Grant E, Reading PC, Hermans PW, Ferwerda G and Diavatopoulos DA | Bacterial lipopolysaccharide inhibits influenza virus infection of human macrophages and the consequent induction of CD8+ T cell immunity | 2014 | J Innate Immun 6(2): 129-139. PubMed link DOI:10.1159/000353905 |
Laurie KL, Engelhardt OG, Wood J and Van Kerkhove MD | Global seroepidemiology: value and limitations | 2014 | Clinical Insights: Influenza Surveillance J. Oxford. eBook, Future Medicine Ltd: 51-66. Online link DOI:10.2217/ebo.13.504 |
Job ER, Bottazzi B, Short KR, Deng YM, Mantovani A, Brooks AG and Reading PC | A single amino acid substitution in the hemagglutinin of H3N2 subtype influenza A viruses is associated with resistance to the long pentraxin PTX3 and enhanced virulence in mice | 2014 | J Immunol. 2014 Jan 1;192(1):271-81. PubMed link DOI:10.4049/jimmunol.1301814 |
Komadina N, McVernon J, Hall R and Leder K | A Historical Perspective of Influenza A(H1N2) Virus | 2014 | Emerg Infect Dis. 20(1):6-12. PubMed link DOI:10.3201/eid2001.121848 |
Short KR, von Kockritz-Blickwede M, Langereis JD, Chew KY, Job ER, Armitage CW, Hatcher B, Fujihashi K, Reading PC, Hermans PW, Wijburg OL and Diavatopoulos DA | Antibodies mediate formation of neutrophil extracellular traps in the middle ear and facilitate secondary pneumococcal otitis media | 2014 | Infect Immun 82(1): 364-370. PubMed link DOI:10.1128/IAI.01104-13 |